Craig McRobbie works directly with inventors to prepare patent applications in the areas of biotechnology, biochemistry, organic chemistry, inorganic chemistry, pharmaceutical chemistry and biology. Mr. McRobbie prosecutes patent applications including corresponding with clients and preparing replies to all USPTO correspondence. Mr. McRobbie handles cases before the USPTO Patent Trial and Appeal Board, and prepares patentability, non-infringement, validity and freedom-to-operate opinions.

Mr. McRobbie has experience with PCT and foreign national stage prosecution of patents on behalf of clients and counsels clients on international patent portfolios. He has practiced in the intellectual property field since 1996, specializing in chemistry and biotechnology.

Speaking Engagements

    Current Speaking Engagements

    Previous Speaking Engagements

  • 11th Annual Practising Law Institute

    PLI

    April 06 2017
  • Japan Intellectual Property Association (JIPA) F8 Course

    JIPA

    October 24 2016
  • 10th Annual Patent Law Institute

    PLI

    April 06 2016

Articles

  • July 24, 2020

    Washington, D.C. NFL Team Loses Race to the Trademark Office: Does it Matter?

    by Michael. T Smith | IPWatchDog

    In surveys throughout the Washington, D.C. metro area, three possible replacement names have emerged as favorites among the fans: Warriors, Red Wolves, and Redtails. Armed with the knowledge of the name change and the relative popularity of the possible replacement names, two enterprising individuals have applied to obtain a federal trademark registration for the marks WARRIORS, WASHINGTON RED WOLVES, and WASHINGTON REDTAILS, respectively. Neither applicant appears to be connected to the owners of the Washington D.C. professional football team.

    Learn More
  • July 10, 2020

    Could good intentions lead to future danger?

    by MaryAnne Armstrong, Ph.D. | LSIPR

    MaryAnne Armstrong, Ph.D. discusses the potential risks to IP rights with open-access to technology, medicines and devices in the fight against COVID-19 in the latest issue of LSIPR.

    Learn More

Presentations